Wyden Statement on FDA Announcement on CBD
January 27, 2023
January 27, 2023
WASHINGTON, Jan. 27 -- Sen. Ron Wyden, D-Oregon, issued the following statement on Jan. 26, 2023:
* * *
U.S. Senator Ron Wyden, D-Ore., released the following statement on the U.S. Food and Drug Administration (FDA) announcement on the regulatory path forward for CBD:
"The current regulatory gray zone for hemp-derived CBD isn't working.
"Regulations are needed to protect consumer safety and to make sure the hemp producers and farmers . . .
* * *
U.S. Senator Ron Wyden, D-Ore., released the following statement on the U.S. Food and Drug Administration (FDA) announcement on the regulatory path forward for CBD:
"The current regulatory gray zone for hemp-derived CBD isn't working.
"Regulations are needed to protect consumer safety and to make sure the hemp producers and farmers . . .